Official Course
Description: MCCCD Approval: 11-28-2006 |
||
CHD110
2007 Spring – 2011 Fall |
LEC
3.0 Credit(s) 3.0 Period(s) 3.0 Load Occ |
|
Pharmacology
of Substances of Abuse and Dependency |
||
Exploration of the pharmacology of substance of abuse and
dependency. Examines the effects of psychopharmacological chemicals on human
physiology. Emphasis on identification and management of substances of abuse
and dependency. Prerequisites: None. |
||
Go to Competencies Go to Outline
MCCCD
Official Course Competencies: |
|
|
|
CHD110 2007
Spring – 2011 Fall |
Pharmacology of Substances of Abuse and Dependency |
1.
|
Explain the function of cells, the peripheral nervous
system, the central nervous system, and other major human physiological
systems. (I, II) |
2.
|
Define homeostasis and explain how various categories of
substances of abuse alter homeostasis. (I, II, III, IV) |
3.
|
Describe how human physiological systems are affected by
various categories of substances of abuse. (I, II, III, IV) |
4.
|
Classify substances of abuse by pharmacological
categories. (IV) |
5.
|
Summarize the effects of chronic substance abuse on
development. (I, II, III, IV, VI) |
6.
|
Explain the physiological effects of detoxification of
various categories of substances of abuse. (V) |
7.
|
Summarize medical and pharmacological interventions
currently used in treating substance abuse and chemical dependency. (V) |
Go to Description Go to top of
Competencies
MCCCD
Official Course Outline: |
||
|
||
CHD110 2007
Spring – 2011 Fall |
Pharmacology of Substances of Abuse and Dependency |
|
|
||
I. Building Blocks A. Cells B. Tissues C. Organs II. Body Systems A. Nervous System 1. Central 2. Peripheral 3. Sympathetic 4. Parasympathetic B. Skeletal C. Muscular D. Endocrine E. Circulatory F. Respiratory G. Digestive III. Homeostasis IV. Taxonomy: Drugs
Classifications A. Sedative-Hypnotics B. Narcotic Analgesics C. Stimulants D. Cannabis E. Inhalants F. Hallucinogens G. Psychotherapeutics H. Over the Counter Drugs V. Pharmacologic/Medical
Interventions A. Detoxification B. Over Dose C. Preventions D. Harm Reduction VI. Effects of Mood
Altering Substances A. Fetus B. Infants C. Children D. Adolescents E. Adults F. Elderly |
|
|